Dr. Rotow on the Implications of Next-Generation ALK Inhibitors in NSCLC

Julia Rotow, MD, discusses the implications of next-generation ALK inhibitors in non–small cell lung cancer.

Website:
Twitter:
Facebook:
LinkedIn:

cancer,oncology,